Emergent BioSolutions Statistics

Total Valuation

LON:0IGA has a market cap or net worth of GBP 263.35 million. The enterprise value is 647.11 million.

Market Cap	263.35M
Enterprise Value	647.11M

Important Dates

The next estimated earnings date is Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	54.28M
Shares Outstanding	n/a
Shares Change (YoY)	+3.58%
Shares Change (QoQ)	+5.72%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	52.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	27.51
PS Ratio	0.35
PB Ratio	0.62
P/TBV Ratio	5.04
P/FCF Ratio	3.60
P/OCF Ratio	3.09
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.29, with an EV/FCF ratio of 8.86.

EV / Earnings	-6.35
EV / Sales	0.91
EV / EBITDA	14.29
EV / EBIT	n/a
EV / FCF	8.86

Financial Position

The company has a current ratio of 6.32, with a Debt / Equity ratio of 1.22.

Current Ratio	6.32
Quick Ratio	3.15
Debt / Equity	1.22
Debt / EBITDA	10.89
Debt / FCF	7.13
Interest Coverage	-0.68

Financial Efficiency

Return on equity (ROE) is -21.63% and return on invested capital (ROIC) is -1.85%.

Return on Equity (ROE)	-21.63%
Return on Assets (ROA)	-1.61%
Return on Invested Capital (ROIC)	-1.85%
Return on Capital Employed (ROCE)	-3.17%
Revenue Per Employee	830,233
Profits Per Employee	-113,175
Employee Count	900
Asset Turnover	0.60
Inventory Turnover	1.89

Taxes

In the past 12 months, LON:0IGA has paid 53.64 million in taxes.

Income Tax	53.64M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.41% in the last 52 weeks. The beta is 2.11, so LON:0IGA's price volatility has been higher than the market average.

Beta (5Y)	2.11
52-Week Price Change	-8.41%
50-Day Moving Average	6.18
200-Day Moving Average	7.71
Relative Strength Index (RSI)	54.65
Average Volume (20 Days)	2,986

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.34

Income Statement

In the last 12 months, LON:0IGA had revenue of GBP 747.21 million and -101.86 million in losses. Loss per share was -1.90.

Revenue	747.21M
Gross Profit	273.99M
Operating Income	-32.20M
Pretax Income	-48.22M
Net Income	-101.86M
EBITDA	47.83M
EBIT	-32.20M
Loss Per Share	-1.90

Full Income Statement

Balance Sheet

The company has 115.40 million in cash and 520.66 million in debt, giving a net cash position of -405.26 million.

Cash & Cash Equivalents	115.40M
Total Debt	520.66M
Net Cash	-405.26M
Net Cash Per Share	n/a
Equity (Book Value)	427.78M
Book Value Per Share	7.85
Working Capital	460.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 85.22 million and capital expenditures -12.15 million, giving a free cash flow of 73.06 million.

Operating Cash Flow	85.22M
Capital Expenditures	-12.15M
Free Cash Flow	73.06M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 36.67%, with operating and profit margins of -4.31% and -13.63%.

Gross Margin	36.67%
Operating Margin	-4.31%
Pretax Margin	-6.45%
Profit Margin	-13.63%
EBITDA Margin	6.40%
EBIT Margin	-4.31%
FCF Margin	9.78%

Dividends & Yields

LON:0IGA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.58%
Shareholder Yield	n/a
Earnings Yield	-38.68%
FCF Yield	27.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0IGA has an Altman Z-Score of 1.22 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.22
Piotroski F-Score	4